CU Medicine studies show oral antiviral drug Paxlovid reduces post-COVID death risk by 42% in immunocompromised patients and its synergy with vaccination

COVID Study Led By Prof. Eng-kiong Yeoh Wins The Best Poster Award

SPHPC Scholars Awarded for Defending Health in Subdivided Unit Households

CUHK and HKU lead a study highlighting higher risks of prediabetes and diabetes under chronic PM2.5 exposure

Prof. Johnson Wang Wins The Most Promising Young Researcher Award

JCSPHPC academics ranked top 1% by citations